Physical and Psychosocial Parameters in Takayasu Arteritis and Behçet's Disease: A Comparative Study With Healthy Controls

NCT ID: NCT07276087

Last Updated: 2025-12-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-11

Study Completion Date

2026-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Systemic vasculitis refers to a group of rare diseases characterized by inflammation of blood vessel walls, which may cause ischemia and structural damage in various organs. Among large-vessel vasculitides, Takayasu arteritis primarily affects the aorta and its main branches, whereas Behçet's disease is a variable vessel vasculitis involving arteries and veins of all sizes. Both conditions can lead to multisystemic involvement and significantly impact physical and psychosocial health.

This observational, case-control study aims to compare multiple physical and psychosocial parameters among individuals with Takayasu arteritis, Behçet's disease, and healthy controls. Assessments will include respiratory and peripheral muscle strength, functional status, exercise capacity, body composition, quality of life, illness perception, and psychological well-being. Measurements will be conducted using standardized clinical tests (such as maximal inspiratory and expiratory pressures, handgrip and limb strength dynamometry, squat test, and six-minute walk test) and validated questionnaires (Health Assessment Questionnaire (HAQ), the Short Form-36 Health Survey (SF-36), the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L), and the Visual Analogue Scale (VAS)).

The study seeks to identify differences between groups and provide a comprehensive understanding of how systemic inflammation in Takayasu arteritis and Behçet's disease affects physical performance, quality of life, and psychosocial health. These findings may help guide physiotherapy, rehabilitation, and multidisciplinary management strategies for patients with systemic vasculitis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Systemic vasculitis represents a heterogeneous group of rare inflammatory diseases that affect blood vessel walls, potentially leading to ischemia, tissue damage, and multi-organ dysfunction. Among them, Takayasu arteritis (TAK) and Behçet's disease (BD) are chronic, relapsing vasculitides characterized by systemic inflammation and variable vessel involvement. These diseases may cause not only organ-specific pathology but also generalized effects on muscle strength, physical function, and psychosocial well-being.

Previous studies have reported reduced physical performance, fatigue, and impaired quality of life in patients with systemic vasculitis. However, there is limited evidence directly comparing physical and psychosocial parameters between individuals with Takayasu arteritis, Behçet's disease, and healthy controls. The current literature lacks a comprehensive approach addressing the multidimensional impact of these diseases on functional and psychological outcomes.

This observational, cross-sectional study aims to fill this gap by evaluating and comparing respiratory and peripheral muscle strength, functional capacity, quality of life, illness perception, and related psychosocial parameters among these three groups. Measurements will include maximal inspiratory and expiratory pressures, handgrip and limb muscle strength via digital dynamometry, functional tests such as the squat test and the six-minute walk test, and standardized self-reported questionnaires including the Health Assessment Questionnaire (HAQ), the Short Form-36 Health Survey (SF-36), the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L), and the Visual Analogue Scale (VAS).

The study is expected to provide a multidimensional understanding of how systemic inflammation in Takayasu arteritis and Behçet's disease affects physical and psychosocial functioning. The findings are anticipated to contribute to the literature by highlighting differences between disease groups and healthy controls and to guide future physiotherapy and rehabilitation strategies aimed at improving overall health and quality of life in individuals with systemic vasculitis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Takayasu Arteritis Behçet's Disease Healthy Controls

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Takayasu Arteritis Group

Participants diagnosed with Takayasu arteritis according to established clinical and imaging criteria.

No intervention (observational study)

Intervention Type OTHER

Participants will not receive any treatment or intervention. The study involves only physical and psychosocial assessments and questionnaires.

Behçet's Disease Group

Participants diagnosed with Behçet's disease according to the International Study Group criteria.

No intervention (observational study)

Intervention Type OTHER

Participants will not receive any treatment or intervention. The study involves only physical and psychosocial assessments and questionnaires.

Healthy Control Group

Age- and sex-matched healthy volunteers with no systemic or chronic disease.

No intervention (observational study)

Intervention Type OTHER

Participants will not receive any treatment or intervention. The study involves only physical and psychosocial assessments and questionnaires.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention (observational study)

Participants will not receive any treatment or intervention. The study involves only physical and psychosocial assessments and questionnaires.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 years or older.
* Diagnosis of Takayasu arteritis according to the American College of Rheumatology (ACR) classification criteria.
* Voluntary participation with written informed consent.


* Age 18 years or older.
* Diagnosis of Behçet's disease according to the International Study Group for Behçet's Disease criteria.
* Voluntary participation with written informed consent.


* Age 18 years or older.
* No history of systemic, rheumatologic, or chronic inflammatory disease.
* Voluntary participation with written informed consent.

Exclusion Criteria

* Pregnancy.
* Presence of psychiatric disorder or ongoing psychiatric treatment.
* Cognitive impairment that may interfere with participation.
* Presence of neurological disease (e.g., hemiplegia, Parkinson's disease, multiple sclerosis, vertigo, epilepsy, etc.).
* History of any surgical operation within the past year.
* Coexisting rheumatic disease other than Takayasu arteritis or Behçet's disease.


* Pregnancy.
* Presence of psychiatric disorder or ongoing psychiatric treatment.
* Cognitive impairment that may interfere with participation.
* Presence of neurological disease (e.g., hemiplegia, Parkinson's disease, multiple sclerosis, vertigo, epilepsy, etc.).
* History of any surgical operation within the past year.
* History of rheumatologic or chronic inflammatory disease.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pamukkale University

OTHER

Sponsor Role collaborator

Uşak University

OTHER

Sponsor Role collaborator

Alanya Alaaddin Keykubat University

OTHER

Sponsor Role collaborator

ÖZLEM NUR TOK YAMAN

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ÖZLEM NUR TOK YAMAN

Lecturer , Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pamukkale University

Denizli, Denizli, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Özlem Nur Tok Yaman, MSc

Role: CONTACT

+90-242-5106060

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bilge Başakcı Çalık, Prof. Dr.

Role: primary

+90-258-296-2000

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PAU-KAEK-2025-17

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Belimumab in Remission of VASculitis
NCT01663623 COMPLETED PHASE3